| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IDEAYA Biosciences, Inc. | SVP, General Counsel | Common Stock | 2,080 | $35,165 | $16.91 | 28 Nov 2025 | Direct |
| IDEAYA Biosciences, Inc. | SVP, General Counsel | Stock Option (right to buy) | 130,000 | 30 Jan 2026 | Direct | ||
| GW PHARMACEUTICALS PLC | Chief Legal Officer | Ordinary Shares | 0 | 05 May 2021 | Direct | ||
| GW PHARMACEUTICALS PLC | Chief Legal Officer | Share Options | 0 | 05 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IDYA | IDEAYA Biosciences, Inc. | 30 Jan 2026 | 3 | +$35,166 | 4 | SVP, General Counsel | 02 Feb 2026, 19:57 |
| IDYA | IDEAYA Biosciences, Inc. | 27 Feb 2025 | 1 | $0 | 4 | SVP, General Counsel | 28 Feb 2025, 18:00 |
| IDYA | IDEAYA Biosciences, Inc. | 26 Sep 2024 | 1 | $0 | 4 | SVP, General Counsel | 27 Sep 2024, 16:25 |
| IDYA | IDEAYA Biosciences, Inc. | 18 Sep 2024 | 0 | $0 | 3 | SVP, General Counsel | 27 Sep 2024, 16:21 |
| /report/000089924321018666-snyder-douglas-b-2021-05-05 | GW PHARMACEUTICALS PLC | 05 May 2021 | 12 | $0 | 4 | Chief Legal Officer | 07 May 2021, 16:15 |